Following the exciting 2022 in-person Communiqué Awards, we are pleased to offer our readers a selection of case studies that ...

A lot has changed for the better over the past few years. As Mike Dixon, the author of this issue’s foreword, writes: “There has been a renewed and reinvigorated focus on diversity, equity and ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Communicating complex medical information has the potential to overwhelm patients and caregivers. The key is blending ...